Watchlist

Watchlist
22nd Century Group, Inc (XXII)
22nd Century Group, Inc (XXII)
2 More Small Caps For The Small Caps Season
In a previous article we introduced four small caps that might benefit from the season for small caps, which is essentially the first couple of months of the year, when these small companies tend to get most of their lift. These companies were Electro Scientific ( ESIO ), 22nd Century Group …
Week 50 Breakout Forecast: Short-Term Picks To Give You An Edge
Positive Acceleration Momentum Stocks This week I have selected 8 breakout stocks from the following sectors: 7 healthcare, 1 industrial goods. Healthcare pharmaceutical and biotechnology stocks were by far the largest representation of breakout stocks in my screener for this week. Detai…
SHU Puppies, The Best Smallcaps For Smallcap Season
As we're moving towards the end of the year, we're also moving towards the season which is highly favorable for small-caps. This time they might have additional rocket fuel in the tank as a result of the coming corporate tax reductions. Here is SA contributor Philip Davis on the impact of the …
22nd Century Hires Former BAT Head of Plant Biotechnology
Juan Sanchez Tamburrino, Ph.D., will take over for retiring Michael R. Moynihan, Ph.D. 22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company focused on tobacco harm reduction and hemp/cannabis research, announced today the hiring of Juan Sanchez Tamburrino, P…
22nd Century Ships 2.4 Million SPECTRUM® Cigarettes for the National Institute on Drug Abuse
XXIIs Proprietary Very Low Nicotine research cigarettes demonstrate the feasibility of FDAs plan to dramatically reduce nicotine in cigarettes 22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company focused on tobacco harm reduction and hemp/can…
Anticipating FDA's "Reduced Nicotine Mandate," 22nd Century Will Discontinue U.S. Sales of RED SUN Brand
22nd Century Awarded New Patent for Low-Tar-to-Nicotine Ratio cigarettes 22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company focused on tobacco harm reduction and hemp/cannabis research, announced today that, in preparation for the planned m…
22nd Century Group Is A Great Long Play
22nd Century Group (XXII) is a plant biotechnology company that specializes in genetic engineering and plant breeding. The company develops technology to increase or decrease nicotine levels through genetic engineering and plant breeding, as well as cannabinoids levels in cannabis plants. Th…
22nd Century Could See Its Stock Soar On The Latest Developments
Recently, 22nd Century (AMEX: XXII ) stock shot up much higher. There was a news announcement from the FDA that directly affected the company. 22nd Century has developed a significantly lower-nicotine tobacco. And the news announcement from the FDA was that it was going to mandate tobacco comp…
Editors' Picks Daily: Is FOMO Responsible For Bitcoin's Meteoric Rise In Price?
Our Editors' Picks Daily is now available for all Seeking Alpha readers! Each article listed below has been selected by our editorial staff as a widely appealing and highly convincing analysis with a clear actionable takeaway. Please use the comment box at the end of this article to express yo…
The Last Cigarette You'll Ever Smoke?
Cigarette smoking has been called one of the greatest public health issues of our time. According to the CDC , it is the leading cause of preventable disease and death in the United States, accounting for 1 in every 5 deaths. In 2015, the CDC reported that about 15 of every 100 adults smoked …
22nd Century Group's (XXII) CEO Henry Sicignano on Q3 2017 Results - Earnings Call Transcript
22nd Century Group, Inc. (XXII) Q3 2017 Results Conference Call November 10, 2017 03:00 PM ET Executives Tom James - General Counsel John Brodfuehrer - CFO Henry Sicignano - President and CEO Analysts James McIlree - Chardan Capital Robert Branciforte - Morgan Stanley A…
22nd Century Group, Inc (XXII)